Metronomic Chemotherapy With Oral Vinorelbine (mVNR) and Capecitabine (mCAPE) in Advanced HER2-negative Breast Cancer Patients: Is It a Way to Optimize Disease Control? Final Results of the VICTOR-2 Study
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-016-4009-3
Full Text
Open PDFAbstract
Available in full text
Date
October 17, 2016
Authors
Publisher
Springer Science and Business Media LLC